Prior large-scale studies, such as analyses from the Framingham Heart Study conducted specifically in cohorts with type 2 diabetes, reported NT-proBNP predicting HF risk with hazard ratios between 1.5 and 2.0 per standard deviation increase [18], yet offering limited mechanistic insight. This evidence concerns the gene NPPB and type 2 diabetes mellitus.